PFNX News and Press, Pfenex Inc. From 09/01/20

NEW YORK , Sept. 1, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP ...

NEW YORK, NY / ACCESSWIRE / August 28, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Pfenex Inc. (NYSE American: PFNX ) relating to its sa...

NEW YORK , Aug. 20, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City , is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may ...

Merger activity increased significantly last week with eight new deals announced and one deal terminated. This is the highest number of deals announced in a single week this year but most of these deals were relatively small compared to the multi-billion-dollar deals we saw in the week prior...

NEW YORK, NY / ACCESSWIRE / August 14, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE: VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siem...

Many types of health care stocks exist in the market. Health care stocks refer to companies with a focus on making medicine, health solutions, fitness equipment, and more. This pandemic with no end in the near future has resulted in many new health care stocks rising. Investors are placing the...

Ligand reports planned acquisition of Pfenex Ligand Pharmaceuticals Inc. ( LGND ) announced that it has inked a definitive agreement with Pfenex Inc. ( PFNX ) for acquiring the latter. The companies expect the transaction to be closed in the fourth quarter of 2020, subject to required re...

Gainers:  Biofrontera (NASDAQ: BFRA )   +75% . More news on: Biofrontera AG, Pfenex Inc., Oxbridge Re Holdings Limited, Stocks on the move, , Read more ...

NEW YORK, NY / ACCESSWIRE / August 11, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Pfenex Inc. (NYSE:PFNX) to Ligand Pharmaceuticals Incorporated is fair to Pfenex shareholders. Under the terms of the merger agreement, Pfenex shareholders ...

Oxbridge Re Holdings (NASDAQ: OXBR ) +112%  on Q2 results . More news on: Oxbridge Re Holdings Limited, Pfenex Inc., Immutep Limited, Stocks on the move, , Read more ...